Applicability of a "Pick a Winner" trial design to acute myeloid leukemia

Blood

Volumn 118, Issue 9, 2011, Pages 2389-2394

  Hills, Robert K ^a   Burnett, Alan K ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; AGE DISTRIBUTION; CLINICAL RESEARCH; DRUG RESEARCH; ELDERLY CARE; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; UNITED KINGDOM;

EID: 80052420105     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-02-337261     Document Type: Review

References (18)

1. Juliusson G., Antunovic P., Derolf A., et al. Age and acute myeloid leukemia: Real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113(18):4179-4187.
2. Menzin J., Lang K., Earle C., et al. The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med. 2002;162(14):1597-1603. (Pubitemid 34773427)
3. Lowenberg B., Downing J.R., Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341(14):1051-1062. (Pubitemid 29451802)
4. Burnett A.K., Wetzler M., Lowenberg B. Therapeutic advances in acute myeloid leukemia. J Clin Oncol. 2011;29(5):475-486.
5. Parmar M.K., Barthel F.M., Sydes M., et al. Speeding up the evaluation of new agents in cancer. J Natl Cancer Inst. 2008; 100(17):1204-1214.
6. Walter R.B., Appelbaum F.R., Tallman M.S., et al. Shortcomings in the clinical evaluation of new drugs: Acute myeloid leukemia as paradigm. Blood. 2010;116(14):2420-2428.
7. Royston P., Parmar M.K., Qian W. Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer. Stat Med. 2003;22(14):2239-2256. (Pubitemid 36926938)
8. Sargent D.J., Goldberg R.M. A flexible design for multiple armed screening trials. Stat Med. 2001;20(7):1051-1060.
9. Appelbaum F.R., Gundacker H., Head D.R., et al. Age and acute myeloid leukemia. Blood. 2006;107(9):3481-3485.
10. Kantarjian H., O'Brien S., Cortes J., et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome. Cancer. 2006;106(5):1090-1098.
11. Burnett A.K., Milligan D., Prentice A.G., et al. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. Cancer. 2007;109(6):1114-1124. (Pubitemid 46435390)
12. Burnett A.K., Hills R.K., Milligan D.W., et al. Low dose Ara-C versus low dose Ara-C and tipifarnib: Result of the UK NCRI AML16 "Pick a Winner" comparison [abstract]. Blood. 2008;112(11):Abstract 2962.
13. Burnett A.K., Hills R.K., Hunter A., et al. The addition of arsenic trioxide to low dose Ara-C in elderly patients with AML does not improve outcome. Leukemia. 2011;25(7):1122-1127.
14. Cashen A.F., Schiller G.J., O'Donnell M.R., et al. Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia. J Clin Oncol. 2010;28(4):556-561.
15. Fenaux P., Mufti G.J., Hellstrom-Lindberg E., et al. Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia. J Clin Oncol. 2010;28(4):562-569.
16. Fenaux P., Mufti G.J., Hellstrom-Lindberg E., et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: A randomised, open-label, phase III study. Lancet Oncol. 2009;10(3):223-232.
17. Burnett A.K., Hills R.K., Hunter A.E., et al. The addition of gemtuzumab ozogamicin to low dose Ara-C improves remission rates but not survival: Results of the UK LRF AML14 and NCRI AML16 "Pick a Winner" comparison [abstract]. Blood. 2010;116(21):Abstract 18.
18. Measuring effectiveness and cost effectiveness: the QALY. http://www.nice.org.uk/newsroom/features/ measuringeffectivenessandcosteffectivenesstheqaly.jsp. Accessed February 9, 2011.